Publication:
Circ-SFMBT2 facilitates the malignant growth of acute myeloid leukemia cells by modulating miR-582-3p/ZBTB20 pathway

Thumbnail Image
Files
Chang-37-137-149-2022.pdf(23.51 MB)
Date
2022
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Chang, Wei ; Shang, Zhen ; Ming, Xi ; Wu, Jiaying ; Xiao, Yi
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-398
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Background. Acute myeloid leukemia (AML) is a highly heterogeneous hematological malignancy. Circular RNAs (circRNAs) play crucial roles in AML progression. This study aimed to explore the function and potential mechanism of circRNA Scm like with four mbt domains 2 (circ-SFMBT2; hsa_circ_0017639) in AML. Methods. The levels of circ-SFMBT2, microRNA582-3p (miR-582-3p) and zinc finger and BTB domain containing 20 (ZBTB20) were measured by quantitative real-time PCR and Western blot. Cell Counting Kit-8 (CCK-8), colony formation, flow cytometry and transwell assays were used to evaluate cell proliferation, apoptosis, migration and invasion. Glycolysis was assessed by detecting glucose consumption, lactate production and ATP/ADP ratios. The related protein expression was examined by Western blot. The binding relationship between miR-582-3p and circSFMBT2/ZBTB20 was verified by dual-luciferase reporter assay. Results. Circ-SFMBT2 and ZBTB20 levels were elevated, while miR-582-3p level was reduced in AML patients and cells. Depletion of circ-SFMBT2/ZBTB20 impeded proliferation, migration, invasion and glycolysis and induced apoptosis in AML cells. Moreover, circ-SFMBT2 facilitated AML progression by sponging miR-582-3p, and miR-582-3p targeted ZBTB20 to hinder AML development. Conclusion. Knockdown of circ-SFMBT2 suppressed AML progression by regulating the miR582-3p/ZBTB20 axis, which might provide a potential therapeutic strategy for AML.
publication.page.subject
Acute myeloid leukemia , circ-SFMBT2 , miR-582-3p , ZBTB20
Citation
Histology and Histopathology Vol. 37, nº2 (2022)
URI
http://hdl.handle.net/10201/128287
item.page.embargo
Collections
Histology and histopathology Vol.37, nº2 (2022)
Ir a Estadísticas